Letters, Testimony & Comments

August 16, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the U.S. Council for International Business's response to the U.S. Trade Representative's Federal Register notice of July 25, 2007, requesting...
July 30, 2007
Dear Senator: We are writing to convey our strong support for clean, renewable and domestic energy production. Accordingly, we urge you to support efforts in the Senate to approve energy tax legislation that will help promote the production and...
July 17, 2007
The Biotechnology Industry Organization (BIO) is pleased to submit these comments in response to the supplemental proposals for plant-incorporated protectants derived from plant viral coat protein genes (PVCP-PIPs) and for plant virus coat...
July 13, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments to the Department of Health and Human Services (HHS) on the HHS Public Health Emergency Medical Countermeasure Enterprise Implementation Plan for...
July 13, 2007
The Biotechnology Industry Organization (BIO) is pleased to submit these comments in response to the Advance Notice of Proposed Rulemaking (ANPRM) for Plant-Incorporated Protectants (PIPs); Potential Revisions to Current Production Regulation...
July 11, 2007
Re: Docket No. 2007N–0121: Use of Medication Guides to Distribute Drug Risk Information to Patients Dear Sir or Madam: The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide the following comments regarding...
June 29, 2007
In light of the upcoming U.S.-China Joint Commission on Commerce and Trade (JCCT) meeting in August, the American Seed Trade Association (ASTA) and Biotechnology Industry Organization (BIO) would like to highlight three concerns regarding...
June 22, 2007
I'm writing on  behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on questions pertaining to international efforts t0 harmonize substantive requirements of patient laws, dated May 3...
June 13, 2007
Re: Proposed Decision Memorandum for Erythropoiesis Stimulating Agents (ESAs) for Non-Renal Disease Indications (CAG-00383N) Dear Dr. Phurrough: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the...
June 13, 2007
Dear Acting Administrator Norwalk: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare and Medicaid Services’ (CMS) proposed rule regarding the hospital inpatient prospective...
June 6, 2007
June 6th, 2007 The Honorable Nancy Pelosi Office of the Speaker H-232, US Capitol Washington, DC 20515 Dear Speaker Pelosi: As President & CEO of the Biotechnology Industry Organization (BIO), I am writing to express BIO’s...
June 6, 2007
Chairman Leahy, Ranking Member Specter, and Members of the Committee, I am pleased to testify before you today on the critically important topic of patent reform. On behalf of the Biotechnology Industry Organization, of which my company Alkermes...
June 1, 2007
BIO's Comments on the SACGHS draft report.